Back to News
Market Impact: 0.42
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 20, 2026 in Fractyl Health, Inc. Lawsuit
Source: GlobeNewswire
Legal & LitigationHealthcare & BiotechManagement & GovernanceCompany Fundamentals
Fractyl Health CEO Harith Rajagopalan and former CFO Lisa A. Davidson face Section 20(a) control-person claims tied to allegations that Revita DMR efficacy data was overstated. GUTS shares lost approximately 74.86% over two trading days, signaling severe investor concern over the company's clinical-data disclosures and governance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.78
Ticker Sentiment
GUTS-0.95
More News
- Grab aims for 'next level' in financial services with purchase of buy-now pay-later platform Atome
- China's AI leaders keep quiet despite U.S. 'publicity' on tech risks
- Exclusive-Malaysia talks to rival airlines as it monitors AirAsia’s financial health, sources say
- Is Amazon Stock a Buy After Its Best Quarter in Years?
- Australia’s Reliance Worldwide agrees to Brookfield’s $2.9 billion buyout bid
- Trip.com swings to Q2 loss after $763 million antitrust penalty